Cargando…

Structural mechanism of allosteric activation of TRPML1 by PI(3,5)P(2) and rapamycin

Transient receptor potential mucolipin 1 (TRPML1) is a Ca(2+)-permeable, nonselective cation channel ubiquitously expressed in the endolysosomes of mammalian cells and its loss-of-function mutations are the direct cause of type IV mucolipidosis (MLIV), an autosomal recessive lysosomal storage diseas...

Descripción completa

Detalles Bibliográficos
Autores principales: Gan, Ninghai, Han, Yan, Zeng, Weizhong, Wang, Yan, Xue, Jing, Jiang, Youxing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: National Academy of Sciences 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8851561/
https://www.ncbi.nlm.nih.gov/pubmed/35131932
http://dx.doi.org/10.1073/pnas.2120404119
_version_ 1784652845362970624
author Gan, Ninghai
Han, Yan
Zeng, Weizhong
Wang, Yan
Xue, Jing
Jiang, Youxing
author_facet Gan, Ninghai
Han, Yan
Zeng, Weizhong
Wang, Yan
Xue, Jing
Jiang, Youxing
author_sort Gan, Ninghai
collection PubMed
description Transient receptor potential mucolipin 1 (TRPML1) is a Ca(2+)-permeable, nonselective cation channel ubiquitously expressed in the endolysosomes of mammalian cells and its loss-of-function mutations are the direct cause of type IV mucolipidosis (MLIV), an autosomal recessive lysosomal storage disease. TRPML1 is a ligand-gated channel that can be activated by phosphatidylinositol 3,5-bisphosphate [PI(3,5)P(2)] as well as some synthetic small-molecule agonists. Recently, rapamycin has also been shown to directly bind and activate TRPML1. Interestingly, both PI(3,5)P(2) and rapamycin have low efficacy in channel activation individually but together they work cooperatively and activate the channel with high potency. To reveal the structural basis underlying the synergistic activation of TRPML1 by PI(3,5)P(2) and rapamycin, we determined the high-resolution cryoelectron microscopy (cryo-EM) structures of the mouse TRPML1 channel in various states, including apo closed, PI(3,5)P(2)-bound closed, and PI(3,5)P(2)/temsirolimus (a rapamycin analog)-bound open states. These structures, combined with electrophysiology, elucidate the molecular details of ligand binding and provide structural insight into how the TRPML1 channel integrates two distantly bound ligand stimuli and facilitates channel opening.
format Online
Article
Text
id pubmed-8851561
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher National Academy of Sciences
record_format MEDLINE/PubMed
spelling pubmed-88515612022-02-18 Structural mechanism of allosteric activation of TRPML1 by PI(3,5)P(2) and rapamycin Gan, Ninghai Han, Yan Zeng, Weizhong Wang, Yan Xue, Jing Jiang, Youxing Proc Natl Acad Sci U S A Biological Sciences Transient receptor potential mucolipin 1 (TRPML1) is a Ca(2+)-permeable, nonselective cation channel ubiquitously expressed in the endolysosomes of mammalian cells and its loss-of-function mutations are the direct cause of type IV mucolipidosis (MLIV), an autosomal recessive lysosomal storage disease. TRPML1 is a ligand-gated channel that can be activated by phosphatidylinositol 3,5-bisphosphate [PI(3,5)P(2)] as well as some synthetic small-molecule agonists. Recently, rapamycin has also been shown to directly bind and activate TRPML1. Interestingly, both PI(3,5)P(2) and rapamycin have low efficacy in channel activation individually but together they work cooperatively and activate the channel with high potency. To reveal the structural basis underlying the synergistic activation of TRPML1 by PI(3,5)P(2) and rapamycin, we determined the high-resolution cryoelectron microscopy (cryo-EM) structures of the mouse TRPML1 channel in various states, including apo closed, PI(3,5)P(2)-bound closed, and PI(3,5)P(2)/temsirolimus (a rapamycin analog)-bound open states. These structures, combined with electrophysiology, elucidate the molecular details of ligand binding and provide structural insight into how the TRPML1 channel integrates two distantly bound ligand stimuli and facilitates channel opening. National Academy of Sciences 2022-02-07 2022-02-15 /pmc/articles/PMC8851561/ /pubmed/35131932 http://dx.doi.org/10.1073/pnas.2120404119 Text en Copyright © 2022 the Author(s). Published by PNAS. https://creativecommons.org/licenses/by/4.0/This open access article is distributed under Creative Commons Attribution License 4.0 (CC BY) (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Biological Sciences
Gan, Ninghai
Han, Yan
Zeng, Weizhong
Wang, Yan
Xue, Jing
Jiang, Youxing
Structural mechanism of allosteric activation of TRPML1 by PI(3,5)P(2) and rapamycin
title Structural mechanism of allosteric activation of TRPML1 by PI(3,5)P(2) and rapamycin
title_full Structural mechanism of allosteric activation of TRPML1 by PI(3,5)P(2) and rapamycin
title_fullStr Structural mechanism of allosteric activation of TRPML1 by PI(3,5)P(2) and rapamycin
title_full_unstemmed Structural mechanism of allosteric activation of TRPML1 by PI(3,5)P(2) and rapamycin
title_short Structural mechanism of allosteric activation of TRPML1 by PI(3,5)P(2) and rapamycin
title_sort structural mechanism of allosteric activation of trpml1 by pi(3,5)p(2) and rapamycin
topic Biological Sciences
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8851561/
https://www.ncbi.nlm.nih.gov/pubmed/35131932
http://dx.doi.org/10.1073/pnas.2120404119
work_keys_str_mv AT ganninghai structuralmechanismofallostericactivationoftrpml1bypi35p2andrapamycin
AT hanyan structuralmechanismofallostericactivationoftrpml1bypi35p2andrapamycin
AT zengweizhong structuralmechanismofallostericactivationoftrpml1bypi35p2andrapamycin
AT wangyan structuralmechanismofallostericactivationoftrpml1bypi35p2andrapamycin
AT xuejing structuralmechanismofallostericactivationoftrpml1bypi35p2andrapamycin
AT jiangyouxing structuralmechanismofallostericactivationoftrpml1bypi35p2andrapamycin